Reduced immunogenicity of the mRNA vaccine BNT162b2 in patients with IPF
T Karampitsakos, O Papaioannou, I Dimeas, P Tsiri, V Sotiropoulou, I Tomos, I Papanikolaou, M Katsaras, P Kirgou, Z Daniil, K Gourgoulianis, D Papalexatos, F Sampsonas, E Manali, S Papiris, D Bouros, A Tzouvelekis
European Respiratory Journal Sep 2022, 60 (suppl 66) 972; DOI: 10.1183/13993003.congress-2022.972